MedTrace Logo

Photoprotection Efficacy With Sunscreen Formulas Containing the Cyclic Merocyanine Long-UVA Absorber MCE Under Long-UVA Exposure

NCT04865094 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-04-29

No results posted yet for this study

Summary

To evaluate the photo-protector effect of BC\_3 (E212657) formulated in SPF compared to SPF alone on long-UVA induced pigmentation in healthy volunteers.

Conditions

  • Pigmentation
  • Redness

Interventions

OTHER

cyclic merocyanine

long-UVA absorber

OTHER

placebo

placebo

Sponsors & Collaborators

  • L'Oreal

    lead INDUSTRY

Principal Investigators

  • ALINA GHITA, PhD · CIDP Biotechnology S.R.L

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-29
Primary Completion
2021-04-29
Completion
2021-04-29

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04865094 on ClinicalTrials.gov